Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers
NCT00143741
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
End-Stage Kidney Disease
Interventions
DRUG:
Atorvastatin (Lipitor)
Sponsor
University of Chicago